A Novel Hydrogen Gas Treatment delivered via Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome

Keibun, L., Fior, G., Nchafatso, O., Nonaka, H., Milani, A., Abbate, G., Hoshino, K., Portadino, S., Shinichi, I., Sato, K., Sato, K., Gandini, L., Sun, K.R., Heinsar, S., Farah, S., Ainola, C., Passmore, M., Panduru, R., Bouquet, M., Wilson, E., Hyslop, K., McInerney, M., Zheng, C., McGrath, C., Li Bassi, L., Suen, J., Fraser, J. Intensive Care Medicine Experimental DOI: 10.1186/s40635-024-00658-z

Abstract: Acute Respiratory Distress Syndrome (ARDS) mortality remains high globally. The current standard relies on supportive management up to Extracorporeal Membrane Oxygenation (ECMO) but lacks a definitive solution. Recently, hydrogen gas has drawn fresh interest as it beneficially acts on multiple biological pathways in ARDS development.